Alopecia study is enrolling now in Kenosha. To find out more or see if you qualify, please fill out webform below or call 262-9251280
Title: A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients with Moderate to Severe Alopecia Areata (THRIVE-AA1)
Eligibility: Ages 18-65; diagnosed with alopecia areata; at least 50% scalp hair loss
Sponsor: Concert Pharmaceuticals, Inc.
A clinical research study is currently looking for adults ages 18-65 with a diagnosis of alopecia areata who have lost 50% or more of the hair on their head to participate in a study of an oral investigational drug.
During the course of this study, some people will receive the investigational drug and some placebo (a substance that has no therapeutic effect). The study will explore whether the investigational drug is safe and can help regrow hair.
You may qualify to participate if you:
are 18-65 years of age
have been diagnosed with alopecia areata
have at least 50% scalp hair loss